BGM Group Ltd. (BGM)
BGM Group Ltd. at a glance — key fundamentals, SEC filings, insider buying and selling, and earnings dates.
BGM Group Ltd. (BGM) is a Drug Manufacturers - Specialty & Generic company based in CN with a market capitalization of $64.2M. Revenue declined 46.0% year-over-year and free cash flow was negative at -$3.4M. This page tracks BGM's SEC filings, insider buying and selling, earnings dates, and key fundamentals in one place.
CN · 298 employees · IPO Jan 24, 2003
Valuation
Valuation & price
$0.30 · as of May 26, 2026 · -97.5% vs 52w high
—
P/E ratio
Latest-FY diluted EPS
1.50
P/B ratio
Market cap ÷ book equity
—
Dividend yield
Price — last 12 months
Fundamentals
Key fundamentals
$64.2M
Market cap
-46.0%
Revenue growth (YoY)
16.4%
Gross margin
-$3.4M
Free cash flow (USD)
-$18.1M
Net debt
Net cash position
0.0%
Share dilution
2/6
Graham criteria passed
Defensive-investor screen
Healthcare
Sector
Trajectory
Long-term trends
Revenue by year
2017 → 2024
Free cash flow by year
2017 → 2024
Gross margin by year
2020 → 2024
Value screen
Graham defensive-investor tests
0
Insider buys · 90 days
0
Insider sells · 90 days
Earnings
Last reported: —
Next expected: not yet scheduled
On the tape
Recent SEC & insider activity
Questions
Frequently asked questions
What is BGM Group Ltd.'s market cap?
BGM Group Ltd. (BGM) has a market capitalization of $64.2M.
What is BGM's P/E ratio?
A meaningful P/E ratio is not available for BGM — the company's latest fiscal-year earnings per share is zero, negative, or not yet cached.
What is BGM's price-to-book (P/B) ratio?
BGM trades at 1.50 times book value per share.
Are insiders buying BGM stock?
SEC Form 4 filings show no open-market insider buys at BGM Group Ltd. in the last 90 days (0 sells).
Same arena
Related companies in Drug Manufacturers - Specialty & Generic
Timeline
Every filing, insider trade & earnings on a price-anchored timeline
Filing Analyzer
Search the actual 10-K / 10-Q text with AI research angles
News
Latest press coverage in one feed
Data: SEC EDGAR filings and cached fundamental data; prices and ratios use the most recent cached quote and statements (may lag by up to a day). Educational and research purposes only. Not investment advice.